Macquarie Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-5,992
| Closed | -$200K | – | 2262 |
|
2022
Q3 | $200K | Sell |
5,992
-2,163
| -27% | -$72.2K | ﹤0.01% | 1617 |
|
2022
Q2 | $34K | Hold |
8,155
| – | – | ﹤0.01% | 2152 |
|
2022
Q1 | $94 | Hold |
8,155
| – | – | ﹤0.01% | 1967 |
|
2021
Q4 | $81K | Buy |
8,155
+464
| +6% | +$4.61K | ﹤0.01% | 2002 |
|
2021
Q3 | $100K | Buy |
7,691
+5,761
| +298% | +$74.9K | ﹤0.01% | 1983 |
|
2021
Q2 | $38K | Buy |
1,930
+1,463
| +313% | +$28.8K | ﹤0.01% | 2218 |
|
2021
Q1 | $10K | Sell |
467
-222
| -32% | -$4.75K | ﹤0.01% | 2392 |
|
2020
Q4 | $20K | Hold |
689
| – | – | ﹤0.01% | 2221 |
|
2020
Q3 | $15K | Hold |
689
| – | – | ﹤0.01% | 2223 |
|
2020
Q2 | $15K | Buy |
+689
| New | +$15K | ﹤0.01% | 2238 |
|
2018
Q1 | – | Sell |
-300
| Closed | -$9K | – | 2338 |
|
2017
Q4 | $9K | Buy |
+300
| New | +$9K | ﹤0.01% | 2280 |
|